Jane Street’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$46.3K Buy
+63,313
New +$46.3K ﹤0.01% 5111
2025
Q1
Sell
-22,246
Closed -$30.7K 5697
2024
Q4
$30.7K Sell
22,246
-45,360
-67% -$62.6K ﹤0.01% 5577
2024
Q3
$70.3K Sell
67,606
-140,867
-68% -$147K ﹤0.01% 5553
2024
Q2
$361K Sell
208,473
-153,089
-42% -$265K ﹤0.01% 4835
2024
Q1
$864K Sell
361,562
-192,334
-35% -$460K ﹤0.01% 3392
2023
Q4
$1.84M Buy
553,896
+315,258
+132% +$1.05M ﹤0.01% 2600
2023
Q3
$893K Sell
238,638
-248,995
-51% -$931K ﹤0.01% 3028
2023
Q2
$2.08M Buy
487,633
+380,692
+356% +$1.63M ﹤0.01% 2380
2023
Q1
$731K Buy
106,941
+93,730
+709% +$641K ﹤0.01% 3223
2022
Q4
$105K Sell
13,211
-10,596
-45% -$83.9K ﹤0.01% 4671
2022
Q3
$229K Sell
23,807
-64,002
-73% -$616K ﹤0.01% 4440
2022
Q2
$635K Buy
87,809
+35,421
+68% +$256K ﹤0.01% 3306
2022
Q1
$677K Buy
52,388
+35,782
+215% +$462K ﹤0.01% 3422
2021
Q4
$265K Sell
16,606
-19,784
-54% -$316K ﹤0.01% 4146
2021
Q3
$585K Sell
36,390
-9,775
-21% -$157K ﹤0.01% 3258
2021
Q2
$639K Buy
46,165
+21,745
+89% +$301K ﹤0.01% 3147
2021
Q1
$356K Sell
24,420
-25,260
-51% -$368K ﹤0.01% 3740
2020
Q4
$863K Buy
49,680
+3,342
+7% +$58.1K ﹤0.01% 2255
2020
Q3
$850K Buy
+46,338
New +$850K ﹤0.01% 1949
2020
Q2
Hold
0
4001
2020
Q1
Sell
-12,671
Closed -$228K 3460
2019
Q4
$228K Buy
12,671
+1,721
+16% +$31K ﹤0.01% 2906
2019
Q3
$222K Sell
10,950
-8,239
-43% -$167K ﹤0.01% 2971
2019
Q2
$424K Buy
+19,189
New +$424K ﹤0.01% 2425
2017
Q3
Sell
-19,279
Closed -$277K 2912
2017
Q2
$277K Buy
+19,279
New +$277K ﹤0.01% 2354